Analyst Ratings for Genmab A/S (GMAB)
GMAB Rating Summary
GMAB Price Target Summary
- Highest: $43.00 (TD Cowen)
- Lowest: $30.50 (Goldman Sachs)
- Average: $37.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$37.80 (+30.9%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Rating Score: 7.5 / 10
Percentile Rank: 79%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/22/2026 | TD Cowen | Yaron Werber | Upgrade | Buy (Hold) |
43.00 (32.00) |
28.37 (28.87) |
1.76% | Details |
| 5/27/2026 | Truist Securities | Gregory Renza | New Coverage | Buy (N/A) |
40.00 (N/A) |
26.89 (28.87) |
7.36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
